A study by the Bernard Malissen (CIML CNRS, Inserm, AMU Marseille), M. Gstaiger (IMSB) and R. Aebersold (IMSB) groups  which appeared in Cell Reports, identifies using proteomics and mouse models molecular mechanisms that might account for some of the failures observed during immunotherapy...…

Le Pr Eric Vivier, DVM, PhD, vient d’être élu Membre de l’Organisation Européenne de Biologie Moléculaire (EMBO). Professeur en immunologie, Hôpital de la Timone, Assistance-Publique des Hôpitaux de Marseille, Centre d’Immunologie de Marseille Luminy, Aix Marseille Université - INSERM - CNRS, Innate Pharma, Marseille Immunopôle…

The CIML organizes several Scientific and Public events in May 2019..., More information

Webcast of the INSERM 2018 awards ceremony. Pierre GOLSTEIN, DR Inserm at CIML, received the Special Prize for being the first to identify the CTLA-4 protein, now targeted in cancer immunotherapy strategies. Watch the video, including Pierre Golstein's speech between the 32nd and 36th minutes.…

Une équipe  internationale de chercheurs dirigée par Eric Vivier  et associant l'Inserm, le CNRS et Aix Marseille Université (au sein du Centre d’Immunologie de Marseille-Luminy), les sociétés Innate Pharma et MedImmune, en collaboration avec l'Assistance publique des Hôpitaux de Marseille, l'Institut Curie, le centre Léon…

Giovanna CHIMINI "Chevalier dans l'ordre des Palmes Académiques de Aix-Marseille Université"
This award honours members of the academic community, researchers, teachers and others. After twenty years as team leader at the Centre d'Immunologie de Marseille-Luminy, Giovanna CHIMINI is Associate Dean of Research and…

Pierre Golstein, Inserm Special Prize 2018. This year, Inserm has decided to award a Special Prize to highlight a major discovery made at Inserm, upstream of the works rewarded by the Nobel Prize in Physiology of Physiology 2018. Pierre Golstein at the Centre d'Immunologie de Marseille-Luminy, is awarded this…

Eric Vivier's group at the Centre d’Immunologie de Marseille-Luminy (CNRS/Inserm/Aix-Marseille University) has highlighted the heterogeneity of "Natural Killer" (NK) cells in humans and mice, blood and spleen. To do this, they used high throughput single-cell RNA sequencing or scRNA-seq, a state-of-the-art molecular biology…